Siegel M M - OmicsDI

Show results for

Unknown (965)
Transcriptomics (25)
Proteomics (17)
Genomics (5)
Metabolomics (4)
Models (2)
Genomic (1)

Organisms

Homo sapiens (24)
Mus musculus (6)
Trypanosoma brucei (3)
Sus scrofa (2)
Arabidopsis thaliana (2)
Gallus gallus (2)
Leishmania major (1)
Bos taurus (1)
Canis lupus (1)
Danio rerio (1)
Didelphis virginiana (1)
Equus caballus (1)
Escherichia coli (1)
Felis catus (1)
Lontra canadensis (1)
Macaca mulatta (1)
Mammalia (1)
Marmota monax (1)
Odocoileus virginianus (1)
Ovis aries (1)
Sciurus carolinensis (1)
Sus scrofa domesticus (1)
Tursiops truncatus (1)
Ursus americanus (1)

Organisms

Homo sapiens (1)

Repository

biostudies-arrayexpress (25)
pride (13)
EGA (4)
MassIVE (4)
MetaboLights (4)
BioModels (1)
dbGaP (1)
FAIRDOMHub (1)
ENA (1)

Tissue

Cell culture (5)
Epithelial cell (2)
Permanent cell line cell (2)
Bone (1)
Hypothalamus (1)
Plant cell (1)
Rosette (1)
Skeletal muscle (1)
Trunk (1)

Disease

Breast cancer (3)
Mixed disorder as reaction to stress (1)
Sleeping sickness (1)

Technology Type

Mass Spectrometry (13)
Shotgun proteomics (8)
Mass spectrometry (4)
Bottom-up proteomics (4)
Data-dependent acquisition (3)
Illumina HiSeq 2500, Illumina HiSeq 2000 (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Gel-based experiment (1)
HDMSE (1)

Instrument Platform

Q Exactive HF-X (2)
TimsTOF Pro 2 (2)
Liquid Chromatography MS - negative - reverse phase (2)
Gas Chromatography MS - (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - positive - reverse phase (1)
Q Exactive (1)

Publication Date

2014 (8)
2024 (6)
2016 (5)
2013 (4)
2025 (4)
2015 (3)
2011 (3)
2020 (3)
2021 (3)
2023 (2)
2012 (2)
2010 (1)
2008 (1)
2026 (1)
2022 (1)
2019 (1)

CHEBI ID

CHEBI:30769 (3)
CHEBI:72998 (3)
CHEBI:15350 (2)
CHEBI:15354 (2)
CHEBI:16027 (2)
CHEBI:16359 (2)
CHEBI:16761 (2)
CHEBI:17750 (2)
CHEBI:17964 (2)
CHEBI:22653 (2)
CHEBI:24898 (2)
CHEBI:26806 (2)
CHEBI:27849 (2)
CHEBI:28300 (2)
CHEBI:30887 (2)
CHEBI:32816 (2)
CHEBI:55328 (2)
CHEBI:6650 (2)
CHEBI:67249 (2)
CHEBI:71465 (2)
CHEBI:85299 (2)
CHEBI:10022 (1)
CHEBI:10072 (1)
CHEBI:10136 (1)
CHEBI:107239 (1)
CHEBI:111517 (1)
CHEBI:115196 (1)
CHEBI:116314 (1)
CHEBI:1217 (1)
CHEBI:122083 (1)

Metabolite Name

(15Z)-9,12,13-Trihydroxy-15-octadecenoic acid (1)
(3-Methyl-3-oxetanyl)methyl 4-methylbenzenesulfonate (1)
(3S,5R,10R,12S,14S,15R,16R)-3,5,10,14,15-Pentahydroxy-12,16-dimethyl-2-icosanone (1)
(R)-2-hydroxystearic acid (1)
(R)-3-hydroxybutyrylcarnitine (1)
1,2-Dithiocane-3,8-diol (1)
1,4-Bis[pentachloroallyl]-2,5-dichlorobenzene (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4) (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2) (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2) (1)
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) (1)
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) (1)
1-(1-enyl-palmitoyl)-GPE (P-16:0) (1)
1-(1-enyl-stearoyl)-2-linoleoyl-GPE (P-18:0/18:2) (1)
1-(1-enyl-stearoyl)-GPE (P-18:0) (1)
1-(2-{[4,6-Di(1-piperidinyl)-1,3,5-triazin-2-yl]oxy}ethyl)-3-phenylurea (1)
1-(4-Amino-1,2,5-oxadiazol-3-yl)-1,2-triazadien-2-ium (1)
1-Chloro-4-iodobutane (1)
1-Oxo-1,2,4-butanetricarboxylic acid (1)
1-Propanesulfonothioate (1)
1-S-Hexyl-1-thiopentitol (1)
1-[3,5-Bis(benzyloxy)phenyl]acetone (1)
1-arachidonoyl-GPI (20:4) (1)
1-lignoceroyl-GPC (24:0) (1)
1-linolenoyl-GPC (18:3) (1)
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) (1)
1-linoleoyl-GPC (18:2) (1)
1-linoleoyl-GPI (18:2) (1)
1-methyl-4-imidazoleacetate (1)

IsPrivate

False (1)

First Public Date

2024 (1)

Modelling Approach

Constraint-based model (1)

Modification

15.99491 (1)
57.02146 (1)

Study type

Transcription profiling by array (13)
Methylation profiling by array (4)
RNA-seq of non coding RNA (3)
Transcription profiling by RT-PCR (2)
RNA-seq of coding RNA (2)
Comparative genomic hybridization by array (1)

Release Date

2021 (108)
2025 (100)
2022 (96)
2023 (92)
2024 (81)
2020 (81)
2019 (72)
2018 (57)
2016 (52)
2015 (44)
2017 (42)
2014 (40)
2013 (30)
2012 (24)
2011 (21)
2010 (14)
2026 (14)
2008 (8)
2009 (7)
2005 (3)
2003 (2)
2007 (1)
2006 (1)

Lab affiliation

Department of Biological Sciences, University of Alberta (2)
Assistant Professor, Departments of Oncology & Pathology, McGill University Principal Investigator, Cancer Research Program, MUHC-RI 1001 Decarie Blvd, EM2.2218 514.934.1934 ext 76307 Montréal, Canada (1)
Australian Regenerative Medicine Institute, Monash University, Wellington Road, Clayton, VIC 3800, Australia (1)
Biozentrum, University of Basel, 4056 Basel, Switzerland (1)
Department of Animal and Poultry Sciences, Virginia Tech., Blacksburg, VA, USA (1)
Department of Pharmaceutical Sciences Skaggs School of Pharmacy at the University of Colorado - Anschutz medical Cammpus. (1)
Department of Physiology, McGill University, Advanced BioImaging Facility (ABIF), McGill University (1)
Department of Veterinary Sciences, Experimental Parasitology Ludwig-Maximilians-Universität München Leopoldstr. 5 80802 Munich Germany Biomedical Center Munich, Physiological Chemistry Ludwig-Maximilians-Universität München Großhaderner Str. 9 82152 Planegg-Martinsried Germany (1)
Instructor Department of Biochemistry and Molecular Biology University of Arkansas for Medical Sciences (1)
Office of Chief Medical Examiner of the City of New York (1)
Office of the Chief Medical Examiner New York City (1)
Plateforme protéomique 3P5-Necker, Université Paris Descartes - Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, Paris 75014, France. (1)

Tags

xref:PubMed:29382358 (1)

Previous page
1 / 102
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 102
Next page

Sort by:

Relevance

Page size

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.

Not available

S-EPMC4534524 | biostudies-literature

Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma.

Not available

S-EPMC4874204 | biostudies-literature

A Tumor Growth Inhibition Model Based on M-Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single-Agent Carfilzomib Use.

Not available

S-EPMC4759707 | biostudies-literature

Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.

Not available

S-EPMC6894072 | biostudies-literature

Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma.

Not available

S-EPMC4979218 | biostudies-literature

Unique cell cycle-dependent variations in the pluripotent epigenetic landscape define novel cohorts of temporal expressed bivalent genes during hESCs differentiation

By mapping the genomic enrichmentsÂ of H3K4me3 and H3K27me3 modifications in pure populations of hESCs during the G2, mitotic and G1 phases of the cell cycle, we characterize cell cycle-dependent variations in the epigenetic landscape of bivalent genes, altering the current view of mitotic inherita...

ORGANISM(S): Homo sapiens

2015-12-23 | E-GEOD-55502 | biostudies-arrayexpress

Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial.

Not available

S-EPMC4577714 | biostudies-literature

The mitochondrial peroxiredoxin displays distinct roles in different developmental stages of African trypanosomes.

Not available

S-EPMC7218024 | biostudies-literature

Expanding epigenomics to archived FFPE tissues: An evaluation of DNA repair methodologies

A study to evaluate techniques for repairing DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples by direct comparison of FFPE DNA repair methods prior to analysis on genome-wide methylation array to matched fresh frozen (FF) tissues. Formalin-fixed paraffin-embedded tissue from three col...

ORGANISM(S): Homo sapiens

2014-12-17 | E-GEOD-59038 | biostudies-arrayexpress

Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).

Not available

S-EPMC8977745 | biostudies-literature

Previous page
1 / 102
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 102
Next page

Sort by:

Relevance

Page size

1019 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

IsPrivate

First Public Date

Modelling Approach

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets